Stockscreener 앱 받기
0.6687
7.50%
-0.0542
시간 외 거래:
.72
0.0513
+7.67%
전일 마감가:
$0.7229
열려 있는:
$0.7007
하루 거래량:
12.35M
Relative Volume:
15.75
시가총액:
$129.54M
수익:
-
순이익/손실:
$-35.47M
주가수익비율:
-1.1732
EPS:
-0.57
순현금흐름:
$-124.27M
1주 성능:
+1.30%
1개월 성능:
-8.40%
6개월 성능:
-60.66%
1년 성능:
-72.37%
1일 변동 폭
$0.6687
$0.7421
1주일 범위
$0.606
$0.8969
52주 변동 폭
$0.4603
$2.59
Prokidney Corp Stock (PROK) Company Profile
명칭
Prokidney Corp
전화
336-999-7028
주소
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
PROK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
0.6687 | 129.54M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-30 | 개시 | JP Morgan | Neutral |
| 2024-09-10 | 개시 | Guggenheim | Buy |
| 2024-03-07 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-01-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-07-25 | 개시 | BTIG Research | Buy |
| 2022-12-21 | 개시 | Jefferies | Buy |
| 2022-11-10 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-10-18 | 개시 | UBS | Buy |
| 2022-10-14 | 개시 | Citigroup | Buy |
| 2022-09-23 | 개시 | BofA Securities | Buy |
| 2022-09-02 | 개시 | Evercore ISI | Outperform |
모두보기
Prokidney Corp 주식(PROK)의 최신 뉴스
Bank of America Corp DE Buys 16,538 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
Nuveen Asset Management LLC Buys 39,216 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
BNP Paribas Financial Markets Invests $110,000 in ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney Approves Key Proposals at Annual Meeting - TipRanks
Northern Trust Corp Has $1.51 Million Position in ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney quarterly loss grows as it nears two key milestones - Winston-Salem Journal
ProKidney Up 26%, Insiders Still In The Red By US$35m - simplywall.st
Wells Fargo & Company MN Purchases 18,431 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney (PROK) Eyes Key Developments and Strong Financial Outl - GuruFocus
ProKidney Corp. Reports Increased Losses Amid Ongoing R&D - TipRanks
ProKidney (PROK) Eyes Key Developments and Strong Financial Outlook | PROK Stock News - GuruFocus
PROKIDNEY CORP. SEC 10-Q Report - TradingView
ProKidney Reports First Quarter 2025 Financial Results and Business Highlights - The Manila Times
ProKidney Corp. (NASDAQ:PROK) Shares Bought by Barclays PLC - Defense World
Mariner LLC Has $64,000 Stake in ProKidney Corp. (NASDAQ:PROK) - The AM Reporter
Mariner LLC Sells 15,937 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
PROKIDNEY Earnings Preview: Recent $PROK Insider Trading, Hedge Fund Activity, and More - Nasdaq
ProKidney Corp. (NASDAQ:PROK) Shares Bought by Renaissance Technologies LLC - Defense World
JPMorgan Chase & Co. Buys 19,585 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney (PROK) Expected to Announce Quarterly Earnings on Friday - Defense World
The ProKidney Corp (PROK) had a good session last reading, didn’t it? - uspostnews.com
ProKidney Corp (PROK) receives a Neutral rating from JP Morgan - knoxdaily.com
ProKidney Corp Inc. (PROK) Price Performance: The Role of Supply and Demand - investchronicle.com
Gaining Ground: ProKidney Corp (PROK) Closes Higher at 1.08, Up 4.85 - DWinneX
Geode Capital Management LLC Grows Stock Position in ProKidney Corp. (NASDAQ:PROK) - Defense World
Is ProKidney Corp (PROK) positioned for future growth? - Sete News
ProKidney Corp (NASDAQ:PROK)’s 12-Month Price Target Currently Stands At 6 - Marketing Sentinel
Major Investment Alert: Carso De-C Inmobiliaria Acquires ProKidney Shares! - TipRanks
ProKidney Corp [PROK] Records 50-Day SMA of $1.0283 - knoxdaily.com
The Psychology of ProKidney Corp Inc. (PROK) Price Performance: Understanding Market Sentiment - investchronicle.com
Analytical Overview: ProKidney Corp (PROK)’s Ratios Tell a Financial Story - DWinneX
Major Investment Alert: ProKidney Stock Sees New Stakeholder! - TipRanks
Major Investment Alert: ProKidney Stock Acquisition! - TipRanks
Major Investment Alert: ProKidney Stock Sees Significant Purchase! - TipRanks
Greensboro’s Once Great Win Is Now A ProKidney Failure - Rhino Times
Major Investment Alert: ProKidney Stock Sees Big Buy-In! - TipRanks
Control empresarial de capitales purchases $628,847 in ProKidney shares - Investing.com
Control empresarial de capitales purchases $628,847 in ProKidney shares By Investing.com - Investing.com Canada
Sei Investments Co. Makes New $69,000 Investment in ProKidney Corp. (NASDAQ:PROK) - Defense World
Critical Review: Candel Therapeutics (NASDAQ:CADL) & ProKidney (NASDAQ:PROK) - Defense World
PROK stock touches 52-week low at $0.49 amid market challenges - Investing.com India
Institutional owners may take dramatic actions as ProKidney Corp.'s (NASDAQ:PROK) recent 32% drop adds to one-year losses - simplywall.st
Bank of New York Mellon Corp Has $388,000 Holdings in ProKidney Corp. (NASDAQ:PROK) - Defense World
Here's Why We're Watching ProKidney's (NASDAQ:PROK) Cash Burn Situation - Yahoo Finance
Down -38% in 4 Weeks, Here's Why You Should You Buy the Dip in PROKIDNEY CP (PROK) - Yahoo Finance
PROK stock touches 52-week low at $0.94 amid market challenges - Investing.com India
ProKidney Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Prokidney Corp (PROK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Prokidney Corp 주식 (PROK) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Control Empresarial de Capital | Add'l Rep. Persons-see Ex.99-1 |
Apr 17 '25 |
Buy |
0.75 |
25,000 |
18,690 |
73,455,330 |
| Control Empresarial de Capital | Add'l Rep. Persons-see Ex.99-1 |
Apr 16 '25 |
Buy |
0.75 |
100,000 |
74,820 |
73,430,330 |
| Control Empresarial de Capital | Add'l Rep. Persons-see Ex.99-1 |
Apr 15 '25 |
Buy |
0.70 |
468,000 |
326,009 |
73,330,330 |
| Control Empresarial de Capital | Add'l Rep. Persons-see Ex.99-1 |
Apr 14 '25 |
Buy |
0.73 |
268,105 |
194,591 |
72,862,330 |
| Control Empresarial de Capital | Add'l Rep. Persons-see Ex.99-1 |
Apr 10 '25 |
Buy |
0.61 |
1,032,218 |
627,692 |
72,592,325 |
| Control Empresarial de Capital | Add'l Rep. Persons-see Ex.99-1 |
Apr 11 '25 |
Buy |
0.61 |
1,900 |
1,155 |
72,594,225 |
| Weber Darin J. | Chief Regulatory Officer |
Sep 19 '24 |
Sale |
2.50 |
16,412 |
41,030 |
103,480 |
1.11%
1.70%
자본화:
|
볼륨(24시간):